Safety Data Sheet (SDS)

Antimony Trioxide MONTANA BRAND, 50 lb, 25 kg & less than 1,000 lb containers

Version 2.0Revision Date: 05/27/15Print Date: 05/27/15

SECTION 1. PRODUCT AND COMPANY IDENTIFICATION

Product name: Antimony Trioxide, all grades

MONTANA BRAND HT
MONTANA BRAND HTW
MONTANA BRAND MP
MONTANA BRND MPW

MONTANA BRAND LT
MONTANA BRAND LTW
MONTANA BRAND VF
MONTANA BRAND VFW

Common Names: Antimony Oxide, Sb2O3, Antimony (III) oxide, Antimony trioxide

Company:

United States Antimony Corporation
47 Cox Gulch P.O. Box 643
Thompson Falls, MT 59873
United States of America

Telephone: (US) +1 406-827-3523
Fax: (US) +1 406-827-3543

Emergency telephone number:

CHEMTREC

Product Uses:

Package Size:

(US) +1 406-827-3523

(800) 424-9300

Flame retardant synergist, porcelain opacifier, glass fining agent, catalyst, electronics

50 lb bags, 25 kg bags, less than 1,000 lb container


SECTION 2. HAZARDS IDENTIFICATION

Emergency Overview

OSHA Hazards: Limited evidence of a carcinogenic effect.

Target Organs: Lungs

GHS Classification

  • Eye irritation (Category 2B)
  • Skin irritation (Category )
  • Respiratory irritation (Category )
  • Harmful if swallowed (Category )
  • Carcinogenicity (Category 2)
  • Acute aquatic toxicity (Category 3)

GHS Label elements, including precautionary statements

Pictogram: 

Signal Word: Warning

Hazard statement(s)

  • H315 + H320: Causes skin and eye irritation.
  • H: Harmful if swallowed
  • H351: Suspected of causing cancer.
  • H402: Harmful to aquatic life.

Precautionary statement(s)

  • P281: Use personal protective equipment as required.
  • P306 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do so. Continue rinsing.
  • P280: Wear protective gloves/protective clothing
  • P284: Wear respiratory protection

HMIS Classification

  • Health Hazard: 2
  • Chronic Health Hazard: *
  • Flammability: 0
  • Physical Health Hazards: 0

NFPA Rating

  • Health Hazard: 2
  • Fire: 0
  • Reactivity Hazard: 0

Potential Health Effects

  • Inhalation: May cause respiratory tract irritation.
  • Skin: May cause skin irritation.
  • Eyes: May cause eye irritation.
  • Ingestion: May be harmful if swallowed.

SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS

Chemical Family: Non-ferrous metal oxide

Chemical NameFormulaMolecular Wt.CAS No.Weight %
Antimony oxideSb2O3291.52 g/mol1309-64-4>=99’7
ArsenicAs74.92 g/mol13510-46-8<0.1% (as As)
LeadPb207.2 g/mol1317-36-8<0.1 (as Pb)

Synonyms: (common names) are provided in Section 1


SECTION 4. FIRST AID MEASURES

General advice
Move out of dangerous area. Consult a physician. Show this Safety Data Sheet to the doctor in attendance.

If inhaled
If breathed in, move person to fresh air. If not breathing, give artificial respiration. Consult a physician.

In case of skin contact
Wash off with soap with plenty of water for at least 15 minutes. Consult a physician.

In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes. Consult a physician.

If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.


SECTION 5. FIREFIGHTING MEASURES

Conditions of flammability
Not flammable or combustible.

Suitable extinguishing media
Use extinguishing agent suitable for type of surrounding fire.

Hazardous combustion products
Fumes of antimony oxide, arsenic oxide, and lead oxide

Special protective equipment for firefighters
Wear self-contained breathing apparatus, pressure demand, MSHA/NIOSH approved or equivalent, and full protective gear.

Explosion Data

  • Sensitivity to Mechanical Impact: Not sensitive
  • Sensitivity to Static Discharge: Not sensitive

SECTION 6. ACCIDENTAL RELEASE MEASURES

Personal precautions
Use personal protective equipment. Avoid dust formation. Avoid breathing dust, vapors, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas.

Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge to the environment must be avoided.

Methods and materials for containment and cleaning up
Prevent large quantities of this product from contacting vegetation or waterways. Cover with plastic sheet to prevent spreading. Vacuum up, or sweep and shovel up without creating dust and transfer to properly labeled containers. Keep in suitable closed containers for disposal according to Federal, State and local laws.


SECTION 7. HANDLING AND STORAGE

Precautions for safe handling

  • Avoid contact with skin and eyes Avoid formation of dust and aerosols.
  • Provide appropriate exhaust ventilation at places where dust is formed.

Conditions for safe storage

  • Keep in tightly closed, properly labeled containers in a dry and well-ventilated place.

SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION

Components with workplace control parameters

ComponentsCAS-No.ValueControl ParametersBasis
RemarksSuspected human carcinogen
Antimony trioxide1309-64-4TWA0.5 mg/m3USA. Occupational Exposure Limits (OSHA) – Table Z-1 Limits for Air Contaminants
  TWA0.5 mg/m3USA. OSHA – Table Z-1 Limits for Air Contaminants – 1910.1000
 Pneumoconiosis, Lung cancer. Exposure by all routes should be carefully controlled to levels as low as possible. Suspected human carcinogen
  TWA0.5 mg/m3USA. Occupational Exposure Limits (OSHA) – Table Z-1 Limits for Air Contaminants
  TWA0.5 mg/m3USA. OSHA – Table Z-1 Limits for Air Contaminants – 1910.1000
  TWA0.5 mg/m3USA. NIOSH Recommended Exposure Limits

Personal protective equipment

Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate wear a NIOSH/MSHA (US) or CEN (EU) approved dust respirator fitted with type N100 (US) or type P3 (EN 143) (EU) dust cartridges as a back-up to engineering controls. A respiratory protection program that meets OSHA 1910.134 and ANSI Z88.2 requirements must be followed whenever workplace conditions warrant a respirator’s use.

Hand protection
Chemical resistant protective gloves

Eye protection
Safety glasses with side-shields conforming to EN 166. Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166 (EU).

Skin and body protection
Impervious clothing. The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace.

Hygiene measures

  • Handle in accordance with good industrial hygiene and safety practice.
  • Wash hands thoroughly before breaks and at the end of the day.
  • Contaminated clothing should not be allowed out of the workplace.
  • Wash contaminated clothing before reuse.
  • Keep work areas clean.
  • Do not eat, drink, chew gum, use tobacco products, or apply cosmetics in work areas.

SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES

Appearance

  • Form: Powder
  • Color: White
  • Odor: Odorless
  • Odor threshold: not applicable

Safety data

pH: not applicable

Melting/freezing point: 655°C (1,211°F)

Boiling point: 1,425°C (2,594°F)

Flash point: not applicable

Evaporation rate: not applicable

Flammability: non-combustible

Flammability Limit in Air

  • Upper Flammability Limit: non-combustible
  • Lower Flammability Limit: non-combustible

Vapor pressure: none at normal conditions

Vapor density: no information available

Bulk density: ≈60 lbs.ft3

Specific gravity: 5.67 g/cm3

Water solubility: 370±37 µg/L

Solubility in other solvents: no information available

Partition coefficient: not applicable

Auto ignition temperature: not applicable

Decomposition temperature: does not decompose

Viscosity, kinematic: not applicable

Viscosity, dynamic: not applicable

Explosive properties: non-explosive

Oxidizing properties: non-oxidizing

Molecular weight: 291.52 g/mol

Kst: St 0 (0 bar m/s)


SECTION 10. STABILITY AND REACTIVITY

Reactivity: None under normal use conditions

Chemical stability: Stable under normal conditions

Possibility of hazardous reactions: Reaction with strong reducing agents can produce toxic and flammable stibine gas.

Conditions to avoid

Strong acids
Strong bases
Strong oxidizing agents
Strong reducing agents
Hot perchloric acid

Incompatible materials

Strong reducing agents
Strong oxidizing agents

Hazardous decomposition products

Hazardous decomposition products formed under fire conditions: Fumes of antimony oxide, arsenic oxide and lead oxide


SECTION 11. TOXICOLOGICAL INFORMATION

Acute Toxicity

Oral LD50
LD50 Oral – rat >34,600 mg/kg

Inhalation LC50
No data available

Dermal LD50
LD50 Dermal – rabbit >2,000 mg/kg

Other information on acute toxicity

  • LD50 Intraperitoneal – rat 3,250 mg/kg
  • LD50 Intraperitoneal – mouse 172 mg/kg

Skin corrosion/irritation

  • May irritate skin
  • May cause temporary small itchy pustules (antimony measles) in hot and humid conditions.

Serious eye damage/irritation
May irritate eyes; Eyes – rabbit – Mild eye irritation – Draize Test

Respiratory or skin sensitizer
Not a respiratory nor skin sensitizer. (IAOIA Risk Assessment 2004 – 2005)

Information on toxicological effects

Symptoms: No information available

Delayed and immediate effects as well as chronic effects from short and long-term exposure

Acute effects: Gastro-intestinal distress

Chronic toxicity

Prolonged and excessive inhalation exposures to antimony trioxide may result in respiratory effects, antimony pneumoconiosis, pulmonary fibrosis, inflammation of the lungs, airway obstruction, broncospasms, reproductive effects, gastrointestinal upset, liver effects, and neurological effects (muscle weakness, subnormal gait).

Prolonged and excessive oral exposure may result in gastrointestinal discomfort and ulcers, blood effects, liver effects, neurological effects inflammation of the mucous membranes and stomatitis.

In a recent 90 day oral study in male and female rats, no adverse effects were observed at doses of 1000, 5000, and 20000 ppm. The No Adverse Effect Level for antimony trioxide was 20000 ppm for both sexes.

In a developmental study in Sprague-Dewley rats consisting of three treatment groups and a control group, each containing 26 females at doses of 2.6, 4.4, and 6.3 mg/m3, no developmental effects were observed. The LOAEL for material toxicity was established at 2.6 mg/m3. The NOEL for developmental toxicity was 6.3 mg/m3, the highest exposure level evaluated.

Mutagenicity: no data available

Carcinogenicity

Carcinogenicity – rat – Inhalation

Tumorigenic: Carcinogenic by RTECS criteria. Respiration: Lungs, Thorax, Tumors Liver: Tumors

Limited evidence of carcinogenicity in animal studies.

IARC

  • Class 2B: Possibly carcinogenic to humans (antimony)
  • Class2A: Probably carcinogenetic to humans (lead)
  • Class 1: Carcinogenetic to humans (arsenic)

NTP: No component of this product present at levels greater than or equal to 0.1% is identified as a known or anticipated carcinogen by NTP.

OSHA: No component of this product present at levels greater than or equal to 0.1% is identified as a known or anticipated carcinogen by OSHA.

Antimony trioxide has been classified by IRAC as a Class 2B. An IARC 2B material exhibits sufficient evidence in animal tests to be a possible human carcinogen. Antimony oxide production has been determined by ACGIH to be a carcinogenic risk. Antimony trioxide has been identified by the EPA as a suspected lung carcinogen. Historical studies have concluded that exposure to elevated levels of antimony oxide may cause lung carcinoma. However, the most recent study conducted under the EPA’s Voluntary Test Program by the Antimony Oxide Industry Association (AOIA), has concluded that antimony oxide does not cause lung cancer in rats at occupational exposure levels. The levels tested ranged from 0.005 mg/m3 to 6 mg/m3 (from one tenth to ten times the OSHA TWA Threshold Limit Value.

Reproductive toxicity

Reproductive toxicity – rat – inhalation

  • Effects on Fertility: Post-implant mortality (e.g., dead and/or resorbed implants per total number of implants). 
  • Effects on Embryo or Fetus: Fetal Death.

Teratogenicity: no data available

Specific target organ toxicity (STOT) – single exposure (Globally Harmonized System): no data available

Specific target organ toxicity (STOT) – repeated exposure (Globally Harmonized System): See “Repeated dose toxicity” below

Repeated dose toxicity

Prolonged and excessive inhalation exposures to antimony trioxide may result in respiratory effects, antimony pneumoconiosis, pulmonary fibrosis, inflammation of the lungs, airway obstruction, broncospasms, reproductive effects, gastrointestinal upset, liver effects, and neurological effects (muscle weakness, subnormal gait).

Prolonged and excessive oral exposure may result in gastrointestinal discomfort and ulcers, blood effects, liver effects, neurological effects inflammation of the mucous membranes and stomatitis.

In a recent 90 day oral study in male and female rats, no adverse effects were observed at doses of 1000, 5000, and 20000 ppm. The No Adverse Effect Level for antimony trioxide was 20000 ppm for both sexes.

In a developmental study in Sprague-Dewley rats consisting of three treatment groups and a control group, each containing 26 females at doses of 2.6, 4.4, and 6.3 mg/m3, no developmental effects were observed. The LOAEL for material toxicity was established at 2.6 mg/m3. The NOEL for developmental toxicity was 6.3 mg/m3, the highest exposure level evaluated.

Aspiration hazard: no data available

Synergistic effects: no data available

Symptoms of overexposure

  • Reddening of the eyes
  • Skin irritation
  • Eye irritation
  • Respiratory irritation
  • Shortness of breath
  • Nose bleeding
  • Headache
  • Dizziness
  • Nausea
  • Vomiting
  • Gastrointestinal discomfort

Further information: The toxicological properties of this material have not been fully characterized.

NTP

US National Toxicity Program (NTP) Report on Carcinogens: This product contains a component at levels greater than or equal to 0.1% that is identified as probable, possible, or confirmed human carcinogen by the US National Toxicology Program Report on Carcinogens.

IARC

US IARC Monographs on Occupational Exposure to Chemical Agents: This product contains a component at levels greater than or equal to 0.1% that is identified as probable, possible, or confirmed human carcinogen by IARC.

OSHASP

US OSHA Specially Regulated Substances (29 CFR 1910.1001-1050: This product contains a component at levels greater than or equal to 0.1% that is identified as probable, possible, or confirmed human carcinogen by OSHA.

ACGIH

US ACGIH Threshold Limit Values: This product contains a component at levels greater than or equal to 0.1% that is identified as probable, possible, or confirmed human carcinogen by ACGIH.


SECTION 12. ECOLOGICAL INFORMATION

Avoid releases to the environment. Harmful to aquatic life.

Toxicity to fish, LC50

Species: Pimephales promelas (flathead minnow)

  • Dose: 21.9 mg/l
  • Exposure time: 96 h
  • For antimony ion (Sb+3)

Toxicity to daphnia and other aquatic invertebrates, LC50

Species: Daphnia magna (Water flea)

  • Dose: 18.8 mg/l
  • Exposure time: 48 h
  • For antimony ion (Sb+3)

Chronic toxicity to daphnia and other aquatic invertebrates, NOEC

Species: Daphnia magna (Water flea)

  •  Concentration: 1.74 mg/l
  •  Exposure time: 21 d
  • For antimony ion (Sb+3)

Toxicity to algae, EbC50

Species: Raphidocelis subcapatata (freshwater green alga)

  • Dose: >2.4 mg/l
  • Exposure time: 72 h
  • For antimony ion (Sb+3)

Additional ecological information

  • In a 42 day chronic sediment test with Hyalella azteca, growth effects after 28 days resulted in an NOEC of 124 mg/kg dw
  • In a 42 day soil toxicity test with Enchytraeus albidus, mortality and reproduction resulted in the same NOEC and LOEC values of 760 mg/kg dw and 2,012 mg/kg dw, respectively.
  • Inhibition action on bacteria (Pseudomonas putida): At 3.5 mg/l no inhibiting action.

Persistence and degradability: no data available

Bioaccumulative potential: no data available

Mobility in soil: no data available

PBT and vPvB assessment: no data available


SECTION 13. DISPOSAL CONSIDERATIONS

Dispose of waste material in compliance with all federal, state and local laws.

Dispose of waste in an approved waste disposal facility


SECTION 14. TRANSPORT INFORMATION

DOT (US)

  • UN-Number: 3077
  • Proper shipping name: Environmentally hazardous substance, solid, n.o.s.
  • Class: 9:
  • Packing group: III
  • Reportable Quantity (RQ): 1000 lb

IATA

  • UN-Number: 3077
  • Proper shipping name: Environmentally hazardous substance, solid, n.o.s.
  • Class: 9:
  • Packing group: III

Additional information

  • Regulated for transport in the United States only. Not regulated for containers less than 1,000 lbs.

SECTION 15. REGULATORY INFORMATION

Federal regulatory information

OSHA Hazards

  • This material is hazardous under the criteria of the Federal OSHA Hazard Communications Standard 29CFR 1910.1200
  • Carcinogen

SARA Hazard category

  • Acute Health Hazard
  • Chronic Health Hazard

US CERCLA

US Environmental Protection Agency (EPA); The 1980 Comprehensive Environmental Response, Compensation and Liability Act (CERCLA)

Reportable quantity (RQ) 1,000 lbs

Antimony Trioxide CAS 1309-64-4 >=99.7%

US SARA 313

US Environmental Protection Agency (EPA); Title III of the Superfund Amendments and Reauthorization Act (SARA) of 1986 Section 313 Reportable Chemicals List, Toxic chemical listings and deminimis concentrations as amended by US Federal Register Final rules

Deminimis concentration: 1%

This category listing is for chemicals listed under antimony compounds which are designated carcinogenic according to 29 CFR1910.1200(d)(4) which have a De Minimis concentration value of 1.0%

Antimony Trioxide CAS 1309-64-4 >=99.7%

US State Regulations

US MA RTK

US. The Commonwealth of Massachusetts Department of Public Health; Massachusetts Right-to-Know law; The Massachusetts Substance List, 105 CMR 670.000

Massachusetts hazardous substance

Antimony Trioxide CAS1309-64-4 >=99.7%

US NJ RTK

US. New Jersey Department of Environmental Protection; Bureau of Hazardous Substances; New Jersey Right to Know L, Hazardous Substance List (P.L. 1983, C.135, NJSA 34:5A-1 et seq.

Hazardous substance

Antimony Trioxide CAS 1309-64-4 >=99.7%

US PA RTK

US. Commonwealth of Pennsylvania – Department of Labor and Industry; Pennsylvania Code Title 34, Labor and Industry Chapter 323

Environmental hazard, hazardous substance

Antimony Trioxide CAS 1309-64-4 >=99.7%

California Prop. 65

WARNING! This product contains a chemical known to the State of California to cause cancer.

WARNING! This product contains a chemical known to the State of California to cause birth defects or other reproductive harm.

Antimony TrioxideCAS 1309-64-4>=99.7%
Carcinogen
ArsenicCAS 7440-38-2<0.1%
Developmental toxin
Female reproductive toxin
Male reproductive toxin
LeadCAS 7439-92-1<0.1%
Carcinogen
LeadCAS 7439-92-1<0.1%
Developmental toxin
Female reproductive toxin
Male reproductive toxin

The components of this product are reported in the following inventories:

  • TSCA: Listed
  • DSL: Listed
  • EINECS: Listed
  • AICS: Listed
  • ENCS: Listed
  • KECI: Listed
  • PICCS: Listed
  • IECSC: Listed

SECTION 16. OTHER INFORMATION

No additional information